Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis
2015 ◽
Vol 40
(6)
◽
pp. 661-671
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 96
(2)
◽
pp. E465-E466
Keyword(s):
2013 ◽
Vol 32
(1)
◽
pp. 45
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 11
(11)
◽
pp. 1927-1939
◽
Keyword(s):